These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 305401)

  • 1. New aspects in the classification of leukemic cell types by Ia alloantigens and complement receptors.
    Wernet P; Schunter F; Wilms K; Waller HD
    Haematol Blood Transfus; 1977; 20():333-9. PubMed ID: 305401
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of leukemic cells by Ia alloantigens and complement receptors. Surface probes for cell differentiation.
    Barth P; Schunter F; Wilms K; Waller HD; Wernet P
    Bibl Haematol; 1978; 45():124-30. PubMed ID: 371603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological characterization of human chronic lymphatic leukaemia (author's transl)].
    Barboni F; Rovinetti C; Lombardo M; Beltrandi E; Di Marzio A; Tabacchi P; Di Primio R; Geraci L; Battista P; Torlontano G
    Haematologica; 1979 Apr; 64(2):159-72. PubMed ID: 112007
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current possibilities in differential diagnosis of leukemias using surface alloantigens and complement receptors].
    Wernet P; Müller C; Barth P; Schunter F; Wilms K; Waller HD
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1813-5. PubMed ID: 347801
    [No Abstract]   [Full Text] [Related]  

  • 5. Surface markers in leukemias and lymphomas.
    Siegal FP; Filippa DA; Koziner B
    Am J Pathol; 1978 Feb; 90(2):451-60. PubMed ID: 304673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitation of T-antigenic sites and Ig-determinants on leukemic cells by microphotometric immunoautoradiography. Proof of the clonal origin of thymus-derived lymphocytic leukemias.
    Thiel E; Dörmer P; Rodt H; Huhn D; Bauchinger M; Kley HP; Thierfelder S
    Haematol Blood Transfus; 1977; 20():131-45. PubMed ID: 415942
    [No Abstract]   [Full Text] [Related]  

  • 8. Ia antigen expression on human epidermal Langerhans cells.
    Rowden G; Lewis MG; Sullivan AK
    Nature; 1977 Jul; 268(5617):247-8. PubMed ID: 329141
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of T and B cell markers and leukemia--associated antigens on cell surface of human lymphocytic leukemias.
    Pandolfi F; Luzi G; Aiuti F
    Haematol Blood Transfus; 1977; 20():117-24. PubMed ID: 305387
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of Ia-like molecules on the surface of normal and leukemic human cells.
    Schlossman SF; Chess L; Humphreys RE; Strominger JL
    Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1288-92. PubMed ID: 1083525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Fc receptor mediated functions by split products of C3.
    Gergely J; Erdei A; Fábry Z
    Mol Immunol; 1984 Dec; 21(12):1205-10. PubMed ID: 6240595
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes.
    Erdei A; Füst G; Sármay G; Medgyesi GA; Gergely J
    Clin Immunol Immunopathol; 1977 Nov; 8(3):367-76. PubMed ID: 334400
    [No Abstract]   [Full Text] [Related]  

  • 13. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of C3 receptors on B lymphocytes derived from normal and memory marrow cells.
    Baum LL; Miller HC
    Cell Immunol; 1978 Jan; 35(1):124-33. PubMed ID: 304380
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishment and characterization of leukemic T-cell lines, B-cell lines, and null-cell line: a progress report on surface antigen study of fresh lymphatic leukemias in man.
    Minowada J; Tsubota T; Nakazawa S; Srivastava BI; Huang CC; Oshimura M; Sonta S; Han T; Sinks LF; Sandberg AA
    Haematol Blood Transfus; 1977; 20():241-51. PubMed ID: 305398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C3 receptor expression in lymphocytes].
    Kudo T; Okuda T; Tachibana T
    Nihon Rinsho; 1979 May; 37(5):993-1001. PubMed ID: 224224
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute leukemia: the use of surface markers in classification.
    Humphrey GB; Lankford J
    Semin Oncol; 1976 Sep; 3(3):243-51. PubMed ID: 185724
    [No Abstract]   [Full Text] [Related]  

  • 18. The detection of membrane-associated complement components (C 3 and C 4) on circulating human normal and leukemic leukocytes and on cultured cells with monkey erythrocytes.
    Burns GF; Cawley JC
    Eur J Immunol; 1979 Oct; 9(10):791-6. PubMed ID: 118035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Ia alloantigens as cell-differentiation markers of normal and pathologic leukocyte surfaces.
    Wernet P; Betsch C; Barth P; Jaramillo S; Schunter F; Waller HD; Wilms K
    Scand J Immunol; 1977; 6(5):563-74. PubMed ID: 142302
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.